We quantified PD‐L1 expression on TC and used the cut‐off of 1% or higher, based on a previous study using this cut‐off as a predictive biomarker for response to anti‐PD‐L1 therapy in CRC.17 Here, CD274 is linked to colorectal carcinoma.